- Advertisement -spot_img

TAG

Advertisement
John Heiderschedit, Criminal Defense Attorney; Subscription Lawyer; Chicago Lawyer

drug pricing reform

OpEd: lllinois patients are paying for flaws in 340B program

Even with major progress on insulin affordability, many people with diabetes struggle under the weight of a costly system.

Op-Ed: Letter to the Editor

Expanding a program that allows profits to grow without transparency while  also delivering minimal benefit to patients at the point-of-sale risks worsening those challenges rather than solving them. #drug #oped

Community Leaders Raise Concerns Over Proposed Expansion of 340B Drug Program

Critics point to financial data suggesting 340B-participating hospitals in Illinois report significantly higher average patient revenues than non-participating hospitals. #drug #proposals #critics

Latest news